therapeutics

Belimumab versus anifrolumab in adults with systemic lupus erythematosus: an indirect comparison of clinical response at 52 weeks
Binod Neupane, Pragya Shukla, Mahmoud Slim, Amber Martin, Michelle Petri, George K Bertsias, Alfred H J Kim, Antonis Fanouriakis, Roger A Levy, Deven Chauhan, Nick Ballew

Lupus Science & Medicine May 2023, 10 (1) e000907; DOI: 10.1136/lupus-2023-000907
MOONLIGHT study: the design of a comparative study of the effectiveness of belimumab in patients with a history of lupus nephritis from the post-Marketed effectiveness of belimumab cOhOrt and JapaN Lupus NatIonwide reGistry (LUNA) coHorT
Kenei Sada, Noriaki Kurita, Hisashi Noma, Taizo Matsuki, Holly Quasny, Roger A Levy, Angela R Jones-Leone, Kerry Gairy, Nobuyuki Yajima

Lupus Science & Medicine Sep 2022, 9 (1) e000746; DOI: 10.1136/lupus-2022-000746
Comparison of short interval and low dose (SILD) with high dose of cyclophosphamide in the susceptibility to infection in SLE: a multicentrereal-world study
Miao Shao, Miao Miao, Xia Zhang, Xiaoying Zhang, Yuan An, Huifang Guo, Lingyan Lei, Qing Zhao, Yanjie Ding, Jin Lin, Rui Wu, Feng Yu, Yucui Li, Huali Miao, Liyun Zhang, Yan Du, Ruiying Jiao, Lixia Pang, Li Long, Xueming Yao, Xiaofei Shi, Fei Wang, Luping Cui, Lei Zhang, Shengyun Liu, Fuai Lu, Kangkai Luo, Simeng Zhao, Yongfu Wang, Xiao Wu, Qingwen Wang, Hongjiang Liu, Shulin Song, Xiaoyuan Zhou, Xiaoping Zhang, Shumei Shi, Hong Zhu, Yao Chen, Honglian Yu, Jie Wu, Ruiyun Yu, Wenqiang Fan, Shuang Liu, Jian Xu, Zhibin Chen, Lianjie Shi, Jing He, Xuewu Zhang, Zhanguo Li, Ru Li

Lupus Science & Medicine Nov 2022, 9 (1) e000779; DOI: 10.1136/lupus-2022-000779
Sirolimus versus tacrolimus for systemic lupus erythematosus treatment: results from a real-world CSTAR cohort study
Nan Jiang, Mengtao Li, Hongfeng Zhang, Xinwang Duan, Xiaofeng Li, Yongfei Fang, Hongbin Li, Pingting Yang, Hui Luo, Yanhong Wang, Liying Peng, Jiuliang Zhao, Chanyuan Wu, Qian Wang, Xinping Tian, Yan Zhao, Xiaofeng Zeng

Lupus Science & Medicine Jan 2022, 9 (1) e000617; DOI: 10.1136/lupus-2021-000617
To treat or not to treat with immunosuppressive therapy: psychiatric disorders in patients with systemic lupus erythematosus
Rory C Monahan, Anne M E Blonk, Tom WJ Huizinga, Margreet Kloppenburg, Huub A M Middelkoop, Nic J A van der Wee, Gerda M Steup-Beekman

Lupus Science & Medicine Jan 2022, 9 (1) e000629; DOI: 10.1136/lupus-2021-000629
Low-dose belimumab for patients with systemic lupus erythematosus at low disease activity: protocol for a multicentre, randomised, double-blind, placebo-controlled clinical trial
Fangfang Sun, Wenyan Huang, Jie Chen, Liling Zhao, Danting Zhang, Xiaodong Wang, Weiguo Wan, Sheng-Ming Dai, Sheng Chen, Ting Li, Shuang Ye

Lupus Science & Medicine Feb 2022, 9 (1) e000638; DOI: 10.1136/lupus-2021-000638
LLDAS (lupus low disease activity state) and/or remission are associated with less damage accrual in patients with systemic lupus erythematosus from a primarily Mestizo population: data from the Almenara Lupus Cohort
Manuel Francisco Ugarte-Gil, Rocio Violeta Gamboa-Cardenas, Cristina Reátegui-Sokolova, Victor Román Pimentel-Quiroz, Mariela Medina, Claudia Elera-Fitzcarrald, Francisco Zevallos, Cesar Augusto Pastor-Asurza, Jeniffer Lofland, Federico Zazzetti, Chetan S Karyekar, Graciela S Alarcón, Risto Alfredo Perich-Campos

Lupus Science & Medicine Feb 2022, 9 (1) e000616; DOI: 10.1136/lupus-2021-000616
Impact of pregnancy in patients with systemic lupus erythematosus-associated pulmonary arterial hypertension: case series and literature review
Mucong Li, Zhuang Tian, Junyan Qian, Can Huang, Jiuliang Zhao, Qian Wang, Yijun Song, Xinping Tian, Mengtao Li, Juntao Liu, Xiaofeng Zeng

Lupus Science & Medicine Mar 2022, 9 (1) e000636; DOI: 10.1136/lupus-2021-000636
Conceptual framework for defining disease modification in systemic lupus erythematosus: a call for formal criteria
Ronald van Vollenhoven, Anca D Askanase, Andrew S Bomback, Ian N Bruce, Angela Carroll, Maria Dall'Era, Mark Daniels, Roger A Levy, Andreas Schwarting, Holly A Quasny, Murray B Urowitz, Ming-Hui Zhao, Richard Furie

Lupus Science & Medicine Mar 2022, 9 (1) e000634; DOI: 10.1136/lupus-2021-000634
Metformin improves renal injury of MRL/lpr lupus-prone mice via the AMPK/STAT3 pathway
Xiao-cui Chen, Dan Wu, Hong-luan Wu, Hui-yuan Li, Chen Yang, Hong-yong Su, Ze-jian Liu, Xiao-rong Huang, Xing Lu, Li-feng Huang, Shao-ping Zhu, Qing-jun Pan, Ning An, Hua-feng Liu

Lupus Science & Medicine Apr 2022, 9 (1) e000611; DOI: 10.1136/lupus-2021-000611

Main menu

therapeutics

Pages

Log in using your username and password

Main menu

Log in using your username and password

You are here

therapeutics

Pages